SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-046012
Filing Date
2023-08-16
Accepted
2023-08-16 16:16:26
Documents
2
Period of Report
2023-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1669
2 POA DOCUMENT poa.txt EX-24 3661
  Complete submission text file 0001209191-23-046012.txt   6851
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address
Arbet-Engels Christophe (Reporting) CIK: 0001802615 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 231178409